Impax Investor Drops Suit Over Drug Price-Fixing Probe
A shareholder alleging generic-drug maker Impax Laboratories Inc. failed to disclose to investors a federal investigation over possibly collusive market activity has dropped his proposed class action in New Jersey federal...To view the full article, register now.
Already a subscriber? Click here to view full article